The “viral–metabolic” interaction mechanisms and management challenges in chronic hepatitis B combined with metabolic dysfunction-associated fatty liver disease: from clinical evidence to an integrated multidisciplinary framework
The comorbidity of chronic hepatitis B and metabolic dysfunction-associated fatty liver disease involves a bidirectional “virus–metabolism” interaction mechanism, presenting a clinical paradox characterized by improved virological markers alongside an …